APA (7th ed.) Citation

M, M., S, K., N, N., M, D., N, A., & H, G. (2022). Greater angiogenic and immunoregulatory potency of bFGF and 5-aza-2'-deoxycytidine pre-treated menstrual blood stem cells in compare to bone marrow stem cells in rat model of myocardial infarction. BMC cardiovascular disorders, 22(1), 578. https://doi.org/10.1186/s12872-022-03032-7

Chicago Style (17th ed.) Citation

M, Manshori, Kazemnejad S, Naderi N, Darzi M, Aboutaleb N, and Golshahi H. "Greater Angiogenic and Immunoregulatory Potency of BFGF and 5-aza-2'-deoxycytidine Pre-treated Menstrual Blood Stem Cells in Compare to Bone Marrow Stem Cells in Rat Model of Myocardial Infarction." BMC Cardiovascular Disorders 22, no. 1 (2022): 578. https://doi.org/10.1186/s12872-022-03032-7.

MLA (9th ed.) Citation

M, Manshori, et al. "Greater Angiogenic and Immunoregulatory Potency of BFGF and 5-aza-2'-deoxycytidine Pre-treated Menstrual Blood Stem Cells in Compare to Bone Marrow Stem Cells in Rat Model of Myocardial Infarction." BMC Cardiovascular Disorders, vol. 22, no. 1, 2022, p. 578, https://doi.org/10.1186/s12872-022-03032-7.